Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

High-dose therapy and autologous stem cell transplantation (HDT/ASCT) is an effective salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of disease (POD). Since the introduction of rituximab, HDT/ASCT is no longer recommended in first remission. We here explo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Alig, Stefan, Jurinovic, Vindi, Shahrokh Esfahani, Mohammad, Haebe, Sarah, Passerini, Verena, Hellmuth, Johannes C., Gaitzsch, Erik, Keay, William, Tahiri, Natyra, Zoellner, Anna, Rosenwald, Andreas, Klapper, Wolfram, Stein, Harald, Feller, Alfred, Ott, German, Staiger, Annette M., Horn, Heike, Hansmann, Martin L., Pott, Christiane, Unterhalt, Michael, Schmidt, Christian, Dreyling, Martin, Alizadeh, Ash A., Hiddemann, Wolfgang, Hoster, Eva, Weigert, Oliver
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Lymphoid Neoplasia
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509878/
https://ncbi.nlm.nih.gov/pubmed/32941649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002546
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker